TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
NeuroOne Medical Technologies ( (NMTC) ) has issued an update.
On October 6, 2025, NeuroOne Medical Technologies announced a significant increase in their preliminary unaudited product revenue for the fiscal year 2025, reaching a record $9.1 million, a 163% growth from the previous year. This growth is attributed to the expanded use and positive outcomes of their OneRF® Ablation system for epilepsy patients. The company also reported cash and cash equivalents of $6.6 million as of September 30, 2025. The complete financial results are expected in December 2025, and stakeholders are advised to exercise caution as these results are preliminary and subject to adjustments.
The most recent analyst rating on (NMTC) stock is a Buy with a $3.00 price target. To see the full list of analyst forecasts on NeuroOne Medical Technologies stock, see the NMTC Stock Forecast page.
Spark’s Take on NMTC Stock
According to Spark, TipRanks’ AI Analyst, NMTC is a Neutral.
NeuroOne Medical Technologies’ overall score reflects strong revenue growth and positive earnings call sentiment, offset by challenges in profitability and valuation. The technical indicators show moderate strength, but the negative P/E ratio and lack of dividend yield weigh on the valuation. The FDA clearance is a positive development, but its impact is already considered in the earnings call analysis.
To see Spark’s full report on NMTC stock, click here.
More about NeuroOne Medical Technologies
NeuroOne Medical Technologies Corporation is a medical technology company focused on developing and commercializing minimally invasive and high-definition solutions for EEG recording, brain stimulation, and ablation solutions. These are aimed at improving surgical care options and outcomes for patients suffering from neurological disorders such as epilepsy, Parkinson’s disease, dystonia, and essential tremors. The company also explores applications in areas like depression, mood disorders, and artificial intelligence.
Average Trading Volume: 322,976
Technical Sentiment Signal: Buy
Current Market Cap: $46.5M
See more insights into NMTC stock on TipRanks’ Stock Analysis page.